Arrowhead Press Releases 
Arrowhead Reports Fiscal 2010 First Quarter Financial Results
PASADENA, Calif. – Arrowhead Research Corporation (NASDAQ: ARWR) today announced financial results for its fiscal 2010 first quarter ended December 31, 2009.
more...Arrowhead Research to Report First Quarter Fiscal 2010 Financial Results and Host Conference Call on Thursday,
February 11, 2010
PASADENA, Calif. - Arrowhead Research Corporation (NASDAQ: ARWR) today announced that it will report its financial results for the fiscal 2010 first quarter ended December 31, 2009, on Thursday, February 11, 2009 at 4:30 p.m. Eastern time (1:30 p.m. Pacific time). To participate in the conference call, please dial 877-941-4774 or 480-629-9760. Investors may also access a live audio webcast of this conference call on the Company's website.
more...Unidym Adds Malcolm Gillis, Ph.D. to Board of Directors
Sunnyvale, CA - Unidym, Inc., a majority owned subsidiary of Arrowhead Research Corporation (NASDAQ: ARWR), today announced that Malcolm Gillis, Ph.D. has been appointed to its Board of Directors. Dr. Gillis served as the President of William Marsh Rice University from 1993 until 2004 and guided Rice to become a leader in the then emerging field of nanoscience. His distinguished academic career focused on economics and environmental public policy and included appointments at Duke University and Harvard University.
more...Arrowhead appoints Chief Financial Officer
Pasadena, CA - Arrowhead Research Corporation (NASDAQ: ARWR) today announced that Ken Myszkowski has been appointed as the Company's Chief Financial Officer. Mr. Myszkowski brings to Arrowhead a broad range of finance and accounting experience spanning two decades in both the public and private sectors, including, most recently, senior level positions at two publicly traded energy companies and, earlier in his career, in two early stage technology companies.
more...Arrowhead's Portfolio Company, Nanotope, Publishes Preclinical Data Demonstrating Cartilage Regeneration
PASADENA, Calif. - February 2, 2010 - Arrowhead Research Corporation (NASDAQ: ARWR) today announced publication in Proceedings of the National Academy of Sciences (PNAS) of a study using Nanotope's lead compound for cartilage regeneration. The study's authors, which include Nanotope co-founder Dr. Samuel Stupp, showed that Nanotope's bioactive nanofiber system promotes the growth of new cartilage in a rabbit model.
more...Unidym Announces Joint Venture to Market Printable CNT Electronics in Korea
Sunnyvale, CA – Unidym, Inc., a majority owned subsidiary of Arrowhead Research Corporation (NASDAQ: ARWR), today announced that it has signed a definitive agreement to create a joint venture partnership with Wisepower, a publicly traded Korean company (KOSDAQ: 040670), to market and co-develop Unidym’s proprietary film and electronic ink products into the Korean touch panel and display industries.
more...Unidym Completes Licensing Agreements to Expand Use of its Carbon Nanotube IP in Diverse Array of Applications
Sunnyvale, CA – Unidym, Inc., a majority owned subsidiary of Arrowhead Research Corporation (NASDAQ: ARWR), today announced that it has completed three licensing agreements for its nanotechnology intellectual property (IP) for use in applications such as aerospace and military products.
more...Arrowhead Research Corporation Subsidiary Tego Biosciences Sells IP Portfolio to Luna Innovations
PASADENA, California – December 28, 2009 – Arrowhead Research Corporation (NASDAQ: ARWR) today announced that its wholly owned subsidiary, Tego Biosciences, has completed a definitive asset purchase agreement for the sale of its non-cash intellectual property (IP) to Luna Innovations, Inc. (Nasdaq: LUNA), a developer and manufacturer of new-generation products that include pharmaceutical nanomedicines.
more...Arrowhead Reports Fiscal 2009 Fourth Quarter and Full-Year Financial Results
PASADENA, Calif. – December 22, 2009 – Arrowhead Research Corporation (NASDAQ: ARWR) today announced financial results for its fiscal 2009 fourth quarter and full-year ended September 30, 2009.
more...Arrowhead Research to Report Fiscal 2009 Fourth Quarter and Year-End Financial Results and Host Conference Call on Tuesday, December 22, 2009
PASADENA, Calif. — December 21, 2009 — Arrowhead Research Corporation (NASDAQ: ARWR) today announced that it will report its financial results for the fiscal 2009 fourth quarter and year ended September 30, 2009, on Tuesday, December 22, 2009 at 4:30 p.m. Eastern time (1:30 p.m. Pacific time).
more...Arrowhead Announces $3.2 Million Private Placement
PASADENA, California - December 17, 2009 - Arrowhead Research Corporation (NASDAQ: ARWR) today announced that it has raised approximately $3.2 million in gross proceeds from a private placement of approximately 5.0 million units.
more...Arrowhead Subsidiary, Unidym, Enters Into Joint Development Agreement With a Major Liquid Crystal Display (LCD) Manufacturer For Glass Based Liquid Crystal Displays
Sunnyvale, CA - Unidym, Inc, a majority-owned subsidiary of Arrowhead Research Corporation (NASDAQ: ARWR), announced today that it has entered into a joint development agreement with a major liquid crystal display (LCD) manufacturer.
more...Unidym and Nano-C Enter Exclusive License Agreement for Fullerene Derivatives Used in Solar Cells
Sunnyvale, CA - December 2, 2009 - Unidym, Inc., a majority owned subsidiary of Arrowhead Research Corporation (NASDAQ: ARWR), announced today that it has entered an exclusive license agreement with Nano-C for patents covering fullerene derivatives. The license provides Nano-C exclusive rights to U.S. Patent No. 5,739,376 and foreign counterparts in the field of photovoltaics.
more...Arrowhead Subsidiary Unidym, Inc. Enters into Third Year of Joint Development Program with Samsung Electronics for Flexible Displays
Pasadena, CA – November 11, 2009 – Arrowhead Research Corporation (NASDAQ: ARWR) announced today that its majority owned subsidiary, Unidym, Inc., has entered into a joint development agreement with Samsung Electronics Co., Ltd., a leading maker of liquid crystal display (LCD) panels, to extend their successful collaboration into a third year.
more...Arrowhead Subsidiary Calando Pharmaceuticals Expands Board of Directors
Arrowhead Research Corporation (NASDAQ: ARWR) today announced that its majority owned subsidiary, Calando Pharmaceuticals, Inc., has appointed Mostafa Analoui, Ph.D., and Bruce D. Given, MD, to its Board of Directors.
more...Arrowhead CEO Provides Update on Company Strategy and Operations
Arrowhead Research Corporation (NASDAQ: ARWR) President and Chief Executive Officer today issued the following letter to the Company's shareholders:
more...Arrowhead Receives NASDAQ Deficiency Notice Related to Minimum Bid Price
Arrowhead Research Corporation (NASDAQ: ARWR) today announced that it has received a deficiency letter from the NASDAQ Stock Market indicating that based on the Company’s closing bid price for the last 30 consecutive business days, the Company does not comply with the $1.00 minimum bid price as set forth in NASDAQ Marketplace Rule 5550(a)(2).
more...Arrowhead Regains Compliance with NASDAQ Listing Requirements
Arrowhead Research Corporation (NASDAQ: ARWR) today announced that it has received notification from the NASDAQ Stock Market that the Company has regained compliance with the minimum of $2.5 million in stockholders’ equity requirement for continued listing on the NASDAQ Capital Market, pursuant to NASDAQ Marketplace Rule 4310(c)(3).
more...Arrowhead Reports Third Quarter Fiscal 2009 Financial Results
Arrowhead Research Corporation (NASDAQ: ARWR) today announced financial results for its third fiscal quarter ended June 30 2009.
more...Arrowhead Announces Completion of $2.76 Million Private Placement
Arrowhead Research Corporation today announced that it has completed a second and final closing of its private offering with selected institutional and accredited investors bringing the proceeds of the offering to a total of $2.76 million.
more...Arrowhead Research to Report Fiscal Third Quarter 2009 Financial Results and Host Conference Call on Monday, August 10, 2009
PASADENA, Calif. — August 4, 2009 — Arrowhead Research Corporation (NASDAQ: ARWR today announced that it will report its financial results for the third quarter of fiscal 2009 ended June 30, 2009, on Monday, August 10, 2009 at 4:30 p.m. ET (1:30 p.m. PT). To participate in the conference call, please dial 888-846-5003 or 480-629-9856. Investors may also access a live audio webcast of this conference call on the Company's website at www.arrowheadresearch.com.
more...